Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

This research underscores the beneficial impact of the Medicaid Institution for Mental Diseases (IMD) exclusion waivers on psychiatric-specific and all-cause health care resource utilization and costs ...

Merck MRK is expected to face some notable headwinds over the next few years that could affect its long-term growth outlook, ...

The story of Minnesota's pandemic-era food aid scandal is often told as a tale of brazen scammers inside a tight-knit ...

CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care ...

CMS has proposed two new models aimed at curbing Medicare drug spending by linking payments to international benchmarks. The proposals — GUARD for Part D drugs and GLOBE for Part B — are the latest in ...

CMS proposes GUARD and GLOBE models to benchmark Medicare drug prices to international levels, aiming to cut costs and reduce ...

Vijayawada: Cybercrime in Andhra Pradesh remains heavily concentrated in urban centres, with Visakhapatnam, Vijayawada, ...

In this episode of Moving Medicine, learn about the potential benefits and challenges of a new outcome-aligned payment model ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

Trump’s order instructs the attorney general to quickly move ahead with reclassifying marijuana. If that happens, the ...

Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind., Dec.